Guillain-Barré syndrome in a patient infected with SARS-CoV-2, a case report

Alberti, 2020, Guillain-Barré syndrome related to COVID-19 infection, Neurol. Neuroimmunol. Neuroinflamm., 10.1212/NXI.0000000000000741

Baig, 2020, Neurological manifestations in COVID-19 caused by SARS-CoV-2, CNS Neurosci. Ther., 26, 499, 10.1111/cns.13372

Bunschoten, 2019, Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy, Lancet Neurol., 10.1016/S1474-4422(19)30144-9

Galán, 2020, Guillain-Barré syndrome associated with SARS-CoV-2 infection TT - Síndrome de Guillain-Barré asociado a infección por SARS-CoV-2, Neurol

Gutiérrez-Ortiz, 2020, Miller fisher syndrome and polyneuritis cranialis in COVID-19, Neurology, 10.1212/WNL.0000000000009619

Helms, 2020, Neurologic features in severe SARS-CoV-2 infection, N. Engl. J. Med., 10.1056/NEJMc2008597

Kim, 2017, Neurological complications during treatment of Middle East respiratory syndrome, J. Clin. Neurol., 13, 227, 10.3988/jcn.2017.13.3.227

Koga, 2018, Experimental approach in research of Guillain–Barré syndrome: a range of pathogeneses mediated by molecular mimicry, Clin. Exp. Neuroimmunol., 9, 93, 10.1111/cen3.12457

Mao, 2020, Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China, JAMA Neurol., 10.1001/jamaneurol.2020.1127

Sedaghat, 2020, Guillain Barre syndrome associated with COVID-19 infection: a case report, J. Clin. Neurosci., 10.1016/j.jocn.2020.04.062

Toscano, 2020, Guillain–Barré syndrome associated with SARS-CoV-2, N. Engl. J. Med., 10.1056/NEJMc2009191

Virani, 2020, Guillain-Barré syndrome associated with SARS-CoV-2 infection, IDCases, 10.1016/j.idcr.2020.e00771

Zhao, 2020, Guillain-Barre syndrome associated with SARS-CoV-2 infection: causality or coincidence?, Lancet Neurol., 19, 383, 10.1016/S1474-4422(20)30109-5